Genmab A/S (United States) is listed on the Nasdaq and has a market capitalization of $2.61 billion, with shareholders equity totaling $5.96 billion.
The company employs approximately 781 people and operates in the Services sector, within the Commercial Services industry.
Over the past 12 months, Genmab A/S reported $5.03 billion in revenue, generating net income of $841.00 million.
Key financial metrics include a P/E ratio of 3.11, a price-to-book (P/B) ratio of 0.44, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker GMAB.